Press Releases - 2023-03-20

Date	Title	Company
20-Mar-2023	Sustainable Packaging Global Market Report 2023: Stringent Environmental Regulations to Boost Growth - ResearchAndMarkets.com	Businesswire
20-Mar-2023	Azafaros Appoints Chief Operating Officer and Head of Finance	Businesswire
20-Mar-2023	SpyBiotech Receives Grant to Advance Novel SpyVector Platform That Improves Efficacy and Boosting Capability of Adenovirus-based Vaccines Against Current and Future Pandemic Viruses	Businesswire
20-Mar-2023	Milla Pharmaceuticals Inc. and the Alter Pharma Group Announce Launch of a Generic Version of Magnesium Sulfate in Water for Injection, in Non-PVC, Single-Patient Use Containers by Their Partner Athenex Pharmaceutical Division (APD)	Businesswire
20-Mar-2023	GB Sciences' First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson's Disease Has Been Issued in China	Newswire
20-Mar-2023	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
20-Mar-2023	Tuberculous Meningitis Treatment Market is expected to value of US$ 300 Billion by 2023 to 2033	MARKITWIRED
20-Mar-2023	Oxford Nanopore and 4bases Announce Collaboration to Combine Nanopore Sequencing Devices and 4bases Kits to Support Rapid, High-accuracy Analyses in Human and Cancer Genetics, with a First Target of Same-day BRCA1 and BRCA2 Analysis	Businesswire
20-Mar-2023	Oncology-Based In-vivo CRO Market is likely to US$ 2.9 by the end of 2033	MARKITWIRED
20-Mar-2023	Transfusion Dependent Thalassaemia Management Market is a CAGR of 6% by 2023 to 2033	MARKITWIRED
20-Mar-2023	Pleural Diseases Therapeutics Market is anticipated CAGR of 6.5% from 2023 to 2033	MARKITWIRED
20-Mar-2023	Leukocyte Adhesion Deficiency Management Market is projected to reach US$ 15.2 billion by 2033	MARKITWIRED
20-Mar-2023	New Four-Year Data for Genentech’s Evrysdi Reinforce Long-Term Efficacy and Safety Profile in Some of the Most Severely Affected People With Types 2 and 3 Spinal Muscular Atrophy (SMA)	Businesswire
20-Mar-2023	Urinary Retention Therapeutics Market is likely to register CAGR of 8.11% 2033	MARKITWIRED
20-Mar-2023	Venous Ulcer Treatment Market is expected to reach US$ 7.61 billion by 2033	MARKITWIRED
20-Mar-2023	Autosomal Dominant Polycystic Kidney Disease Treatment Market to expand at a 5.97% value CAGR by 2033	MARKITWIRED
20-Mar-2023	Low-Grade Glioma Therapeutics Market is expected to reach US$ 1515.47 Million by 2033, at a CAGR 4.57%	MARKITWIRED
20-Mar-2023	Gene Therapy in CNS Disorder Market is expected to reach US$ 113.04 Billion, at a CAGR 30%	MARKITWIRED
20-Mar-2023	AEVIS VICTORIA SA – Consolidated EBITDA 2022 up by more than 60% to between CHF 125 and 130 million (2021: CHF 78.4m); net profit 2022 will exceed CHF 60 million (2021: CHF 4.6m)	AEVIS VICTORIA SA
20-Mar-2023	Newron reports compelling topline results from all patients in Study 014, its Phase II clinical trial evaluating evenamide as add-on therapy for treatment-resistant schizophrenia	Newron Pharmaceuticals S.p.A.